Forward Raises $100 Million Funding to Deploy AI-Powered CarePods Across US
To improve your local-language experience, sometimes we employ an auto-translation plugin. Please note auto-translation may not be accurate, so read original article for precise information.
Primary healthcare startup Forward successfully raised $100 million in a Series E funding for its flagship product CarePods.
Primary healthcare startup Forward announced it has successfully raised $100 million in a Series E funding round. According to the company, the funds will be used to develop and deploy Forward CarePods that use artificial intelligence to screen and diagnose the health conditions of individuals.
The recent infusion of $100 million in funding was led by blue-chip venture funds like Khosla Ventures, Founders Fund, Samsung Next, Abu Dhabi Investment Authority and Softbank.
It comprises a mix of $50 million in equity financing and debt financing, as reported by The Information.
Founded in 2016, the company describes its flagship product CarePods as “the world’s first AI doctor’s office” — for strategic locations such as malls, gyms, and offices. The initial deployment is underway in prominent metropolitan areas including the San Francisco Bay Area, New York, Chicago and Philadelphia.
Noteworthy figures in the AI field, including Eric Schmidt, John Giannandrea, Demis Hassabis and Mustafa Suleyman are also supporting Forward as backers. The company has bold plans to double its footprint in 2024 for a significant expansion in the company’s reach.
Fusion of AI with Medical Expertise
The AI-powered self-service pods aim to be at the forefront of merging artificial intelligence with medical expertise, delivering advanced diagnostics and personalized health plans. Users stepping into a CarePod will gain access to a suite of health apps such as disease detection, biometric body scans, blood testing and more.
Developed by doctors from prestigious institutions such as Harvard, Johns Hopkins and Columbia, Forward’s proprietary AI can aid a spectrum of diseases including diabetes, hypertension, and mental health issues like depression and anxiety.
The company has ambitious plans to expand its app offerings to include prenatal care, cancer screening and polygenic risk analysis in the future.
Forward’s memberships start at $99 per month, providing users with a mobile app for accessing personalized health data. The platform supports real-time monitoring, risk identification, and in-depth health evaluations through a combination of sensors, lab tests, and vital sign measurements.
Despite its reliance on AI, the company maintains a team of over 100 primary care clinicians who remain integral in making critical care decisions. Forward said its expansion plans align with its commitment to provide accessible and personalized healthcare, setting the stage for an impact on the future of the healthcare landscape.
In line with the Trust Project guidelines, please note that the information provided on this page is not intended to be and should not be interpreted as legal, tax, investment, financial, or any other form of advice. It is important to only invest what you can afford to lose and to seek independent financial advice if you have any doubts. For further information, we suggest referring to the terms and conditions as well as the help and support pages provided by the issuer or advertiser. MetaversePost is committed to accurate, unbiased reporting, but market conditions are subject to change without notice.